Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebbe Langholz

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Gastroenterology|December 25, 2010
Current trends in inflammatory bowel disease: the natural historyEbbe Langholz
Gastroenterology|September 25, 2012
Relative or relevant risk?Ebbe Langholz
Journal of Crohn'S & Colitis|February 4, 2017
The EpiCom Survey-Registries Across Europe, Epidemiological Research and BeyondHannah Gordon, Ebbe Langholz
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: delving into the natural history of Crohn's disease and the impact of medical therapy-authors' replyJohan Burisch, Ebbe Langholz, Pia Munkholm
Alimentary Pharmacology & Therapeutics|April 16, 2022
Letter: the clinical course of Crohn's disease-the Sicilian experience. Authors' replyJohan Burisch, Ebbe Langholz, Pia Munkholm
Alimentary Pharmacology & Therapeutics|September 20, 2021
The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017Johan Burisch, Søren Lophaven, Ebbe Langholz, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Tranexamic acid for upper gastrointestinal bleedingLise Lotte Gluud, Sarah Louise Klingenberg, Ebbe Langholz
Alimentary Pharmacology & Therapeutics|October 29, 2021
Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohortJohan Burisch, Søren Lophaven, Pia Munkholm, et al.
The Cochrane Database of Systematic Reviews|November 22, 2014
Tranexamic acid for upper gastrointestinal bleedingCathy Bennett, Sarah Louise Klingenberg, Ebbe Langholz, et al.
Trends in Pharmacological Sciences|January 23, 2024
Mirikizumab (Omvoh™) for ulcerative colitisAlexander Hammerhøj, Theresa Louise Boye, Ebbe Langholz, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Gastroenterology|December 25, 2010
Current trends in inflammatory bowel disease: the natural historyEbbe Langholz
Gastroenterology|September 25, 2012
Relative or relevant risk?Ebbe Langholz
Journal of Crohn'S & Colitis|February 4, 2017
The EpiCom Survey-Registries Across Europe, Epidemiological Research and BeyondHannah Gordon, Ebbe Langholz
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: delving into the natural history of Crohn's disease and the impact of medical therapy-authors' replyJohan Burisch, Ebbe Langholz, Pia Munkholm
Alimentary Pharmacology & Therapeutics|April 16, 2022
Letter: the clinical course of Crohn's disease-the Sicilian experience. Authors' replyJohan Burisch, Ebbe Langholz, Pia Munkholm
Alimentary Pharmacology & Therapeutics|September 20, 2021
The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017Johan Burisch, Søren Lophaven, Ebbe Langholz, et al.
The Cochrane Database of Systematic Reviews|January 20, 2012
Tranexamic acid for upper gastrointestinal bleedingLise Lotte Gluud, Sarah Louise Klingenberg, Ebbe Langholz
Alimentary Pharmacology & Therapeutics|October 29, 2021
Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohortJohan Burisch, Søren Lophaven, Pia Munkholm, et al.
The Cochrane Database of Systematic Reviews|November 22, 2014
Tranexamic acid for upper gastrointestinal bleedingCathy Bennett, Sarah Louise Klingenberg, Ebbe Langholz, et al.
Trends in Pharmacological Sciences|January 23, 2024
Mirikizumab (Omvoh™) for ulcerative colitisAlexander Hammerhøj, Theresa Louise Boye, Ebbe Langholz, et al.
Pageof 7